Search Within

Andrew Joseph Plodkowski

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (34)
  2. Meeting Abstract (15)
Groups
  1. Body Imaging Service (49)
  2. Department of Pathology and Laboratory Medicine (49)
  3. Radiology, Department of (49)
  4. Department of Medicine (45)
  5. Solid Tumor Oncology Division (43)
  6. Thoracic Oncology (42)

More Groups

People
  1. Matthew Hellmann (24)
  2. Charles Rudin (23)
  3. Mark Kris (23)
  4. Marc Ladanyi (22)
  5. Natasha Rekhtman (21)
  6. Gregory Riely (20)

More People

Years
  1. 2024 (2)
  2. 2023 (7)
  3. 2022 (4)
  4. 2021 (5)
  5. 2020 (7)
  6. 2019 (9)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Journal of Thoracic Oncology (7)
  3. Clinical Cancer Research (6)
  4. Annals of Oncology (4)
  5. Cancer Cell (2)
  6. Cancer Discovery (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. Elsevier Inc. (11)
  3. American Association for Cancer Research (8)
  4. Oxford University Press (5)
  5. Cell Press (2)
  6. Elsevier Ireland Ltd. (2)

More Publishers

Results (49)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular subtypes and clinical outcomes to initial systemic treatment in patients with small cell lung cancer
    Meeting Abstract

    Lai, W. C. V.; Egger, J. V.; Rizvi, H.; Richards, A. L.; Beras, A.; Baine, M. K.; Hsieh, M. S.; Chang, J. C.; Rekhtman, N.; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Clinical characteristics and anti-PD-(L)1 treatment outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer
    Meeting Abstract

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Halpenny, D.; Hellmann, M. D.; Heller, G.; Knezevic, A.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC
    Journal Article

    Hellmann, M. D.; Nabet, B. Y.; Rizvi, H.; Chaudhuri, A. A.; Wells, D. K.; Dunphy, M. P. S.; Chabon, J. J.; Liu, C. L.; Hui, A. B.; Arbour, K. C.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas
    Journal Article

    Schoenfeld, A. J.; Rizvi, H.; Bandlamudi, C.; Sauter, J. L.; Travis, W. D.; Rekhtman, N.; Plodkowski, A. J.; Perez-Johnston, R.; Sawan, P.; Beras, A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas
    Journal Article

    Rekhtman, N.; Montecalvo, J.; Chang, J. C.; Alex, D.; Ptashkin, R. N.; Ai, N.; Sauter, J. L.; Kezlarian, B.; Jungbluth, A.; Desmeules, P.; more...
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • A phase 2 trial of cabozantinib in ROS1-rearranged lung adenocarcinoma
    Meeting Abstract

    Guo, R.; Preeshagul, I.; Schoenfeld, A.; McCarthy, C.; Makhnin, A.; Plodkowski, A.; Ginsberg, M.; Davare, M.; Delasos, L.; Somwar, R.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Multifactorial model to predict response to PD-(L)1 blockade in patients with high PD-L1 metastatic non-small cell lung cancer
    Meeting Abstract

    Arbour, K.; Oprescu, M.; Hakim, J.; Rizvi, H.; Leiserson, M.; Ginsburg, M.; Plodkowski, A.; Sauter, J.; Preeshagul, I.; Gillett, S.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
    Journal Article

    Hastings, K.; Yu, H. A.; Wei, W.; Sanchez-Vega, F.; DeVeaux, M.; Choi, J.; Rizvi, H.; Lisberg, A.; Truini, A.; Lydon, C. A.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Real-world experience and molecular features of response to immune checkpoint blockade in patients with recurrent small cell lung cancer
    Meeting Abstract

    Lai, W. C. V.; Rizvi, H.; Egger, J. V.; Plodkowski, A. J.; Ginsberg, M. S.; Kris, M. G.; Beras, A.; Rekhtman, N.; Poirier, J. T.; Hellmann, M. D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Acute lung injury pattern is a frequent histologic finding in lung tissue following immune checkpoint inhibitor therapy
    Meeting Abstract

    Golden, A.; Imran, S.; Feinstein, M.; Hellmann, M.; Plodkowski, A.; Rekhtman, N.; Rizvi, H.; Travis, W.; Stover, D.; Sauter, J.
    Modern Pathology (2019)

    Fulltext@MSK | Save